These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 1270176
21. Effect of cervical cancer screening in Scandinavia. Day NE. Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876 [Abstract] [Full Text] [Related]
22. Recent trends in recorded incidence and mortality from uterine cancer. Gallagher RP, Elwood JM. Natl Cancer Inst Monogr; 1982 May; 62():83-7. PubMed ID: 7167199 [Abstract] [Full Text] [Related]
23. Female reproductive organs and breast cancer mortality in New Jersey counties and the relationship with certain environmental variables. Najem GR, Greer TW. Prev Med; 1985 Sep; 14(5):620-35. PubMed ID: 3840894 [Abstract] [Full Text] [Related]
24. Evaluation of screening for cervical cancer in Sweden: trends in incidence and mortality 1958-1980. Pettersson F, Björkholm E, Näslund I. Int J Epidemiol; 1985 Dec; 14(4):521-7. PubMed ID: 4086138 [Abstract] [Full Text] [Related]
25. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Singh GK, Miller BA, Hankey BF, Edwards BK. Cancer; 2004 Sep 01; 101(5):1051-7. PubMed ID: 15329915 [Abstract] [Full Text] [Related]
26. Trends in uterine cancer mortality in the Americas, 1955-1988. Bocciolone L, La Vecchia C, Levi F, Lucchini F, Franceschi S. Gynecol Oncol; 1993 Dec 01; 51(3):335-44. PubMed ID: 8112642 [Abstract] [Full Text] [Related]
27. A note on trends in mortality from cancer of the cervix, Ontario and British Columbia, 1950-1971. Sellers AH, McLerie EE. Can J Public Health; 1973 Dec 01; 64(4):364-7. PubMed ID: 4730901 [No Abstract] [Full Text] [Related]
28. Evaluation of mortality data for cervical cancer with special reference to mass screening programs, Denmark, 1961-1971. Grünfeld K, Horwitz O, Lysgaard-Hansen B. Am J Epidemiol; 1975 Apr 01; 101(4):265-75. PubMed ID: 1124757 [Abstract] [Full Text] [Related]
29. Measuring Substance-Related Disorders Using Canadian Administrative Health Databanks: Interprovincial Comparisons of Recorded Diagnostic Rates, Incidence Proportions and Mortality Rate Ratios. Huỳnh C, Kisely S, Rochette L, Pelletier É, Morrison KB, Li S, Hopkin G, Smith M, Burchill C, Lin E, Asbridge M, Jutras-Aswad D, Lesage A. Can J Psychiatry; 2022 Feb 01; 67(2):117-129. PubMed ID: 34569874 [Abstract] [Full Text] [Related]
30. Trends in mortality from uterine cancer in relation to mass screening. Christopherson WM, Scott MA. Acta Cytol; 1977 Feb 01; 21(1):5-9. PubMed ID: 264759 [Abstract] [Full Text] [Related]
31. Optimising the age, number of tests, and test interval for cervical screening in Canada. Shun-Zhang Y, Miller AB, Sherman GJ. J Epidemiol Community Health; 1982 Mar 01; 36(1):1-10. PubMed ID: 7069349 [Abstract] [Full Text] [Related]
33. Screening for cancer of the uterine cervix in Iceland 1965--1978. Johannesson G, Geirsson G, Day N, Tulinius H. Acta Obstet Gynecol Scand; 1982 Mar 01; 61(3):199-203. PubMed ID: 7124352 [Abstract] [Full Text] [Related]
35. Educational inequality in female cancer mortality in Korea. Kim MH, Jung-Choi K, Kim H, Song YM. J Korean Med Sci; 2015 Jan 01; 30(1):1-6. PubMed ID: 25552877 [Abstract] [Full Text] [Related]
39. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide. Mathew A, George PS. Asian Pac J Cancer Prev; 2009 Jan 01; 10(4):645-50. PubMed ID: 19827887 [Abstract] [Full Text] [Related]